| Validation of miRNA prognostic power in hepatocellular carcinoma using expression data of independent datasets Á Nagy, A Lánczky, O Menyhárt, B Győrffy Scientific reports 8 (1), 9227, 2018 | 1234 | 2018 |
| Cross-validation of survival associated biomarkers in gastric cancer using transcriptomic data of 1,065 patients AM Szász, A Lánczky, Á Nagy, S Förster, K Hark, JE Green, ... Oncotarget 7 (31), 49322, 2016 | 921 | 2016 |
| miRpower: a web-tool to validate survival-associated miRNAs utilizing expression data from 2178 breast cancer patients A Lánczky, Á Nagy, G Bottai, G Munkácsy, A Szabó, L Santarpia, B Győrffy Breast cancer research and treatment 160, 439-446, 2016 | 734 | 2016 |
| Determining consistent prognostic biomarkers of overall survival and vascular invasion in hepatocellular carcinoma O Menyhárt, Á Nagy, B Győrffy Royal Society open science 5 (12), 181006, 2018 | 360 | 2018 |
| KRAS driven expression signature has prognostic power superior to mutation status in non‐small cell lung cancer Á Nagy, LS Pongor, A Szabó, M Santarpia, B Győrffy International journal of cancer 140 (4), 930-937, 2017 | 41 | 2017 |
| Internet-based opportunities in breast cancer diagnostics and research Á Nagy, B Gyõrffy Magyar onkologia 60 (4), 273-280, 2015 | 1 | 2015 |
